Nedosiran in pediatric patients with PH1 and relatively preserved kidney function, a phase 2 study (PHYOX8).
Saved in:
| Title: | Nedosiran in pediatric patients with PH1 and relatively preserved kidney function, a phase 2 study (PHYOX8). |
|---|---|
| Authors: | Sas DJ; Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. Sas.David@mayo.edu.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Sas.David@mayo.edu.; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. Sas.David@mayo.edu., Bakkaloglu SA; Department of Pediatric Nephrology, Gazi University, Ankara, Turkey., Belostotsky V; Department of Pediatrics, McMaster Children's Hospital, Hamilton, Canada., Hayes W; Department of Pediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Ariceta G; Pediatric Nephrology, University Hospital Vall d'Hebron, Barcelona, Spain., Zhou J; Novo Nordisk A/S, Lexington, MA, USA., Rawson V; Novo Nordisk A/S, Lexington, MA, USA. |
| Source: | Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2025 Jun; Vol. 40 (6), pp. 1939-1948. Date of Electronic Publication: 2025 Jan 28. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
